首页> 美国卫生研究院文献>Cancers >MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia
【2h】

MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia

机译:MicroRNAS:常规B细胞发育中具有关键作用的基因表达的微小调节因子和B细胞慢性淋巴细胞白血病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The involvement of miRNAs in physiological cellular processes has been well documented. The development of B cells, which is dictated by a miRNA-transcription factor regulatory network, suggests a typical process partly orchestrated by miRNAs. Besides their contribution in normal hematopoiesis, miRNAs have been severally reported to be implicated in hematological malignancies, a typical example of which is B-cell chronic lymphocytic leukemia (B-CLL). Numerous studies have attempted to highlight the regulatory role of miRNAs in B-CLL or establish some of them as molecular biomarkers or therapeutic targets. Thus, a critical review summarizing the current knowledge concerning the multifaceted role of miRNAs in normal B-cell development and B-CLL progression, prognosis, and therapy, is urgent. Moreover, this review aims to highlight important miRNAs in both normal B-cell development and B-CLL and discuss future perspectives concerning their regulatory potential and establishment in clinical practice.
机译:MiRNA在生理细胞过程中的参与已被充分记录。由miRNA转录因子调节网络决定的B细胞的发展表明,MIRNA部分策划了典型的过程。除了它们在正常血液缺血中的贡献外,MIRNA已被同期据报道涉及血液天动恶性肿瘤,其典型的例子是B细胞慢性淋巴细胞白血病(B-CLL)。许多研究试图突出MiRNA在B-CLL中的调节作用,或者将其中一些人作为分子生物标志物或治疗靶标。因此,总结了关于MIRNA在正常B细胞​​发育中的多方面作用的目前知识和B-CLL进展,预后和治疗的临界综述是迫切的。此外,本综述旨在突出正常的B细胞开发和B-CLL中的重要MIRNA,并讨论其关于他们在临床实践中的监管潜力和建立的未来观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号